Skip to content

Effect of Chamomile tea consumption in the treatment of depressed patients with type 2 diabetes

The effect of chamomile tea on depression status, glycemic control, Blood lipid profiles and oxidative stress in depressed patients with type 2 diabetes

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014112820132N1
Enrollment
74
Registered
2015-03-15
Start date
2015-02-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression. Depressive episode, Recurrent depressive disorder

Interventions

Intervention 1: Intervention group will receive daily 3 cups of Chamomile tea at least half an hour after the meal for 12 weeks( each cup of Chamomile tea is produced by putting Chamomile tea bag cont
Treatment - Drugs
Intervention group will receive daily 3 cups of Chamomile tea at least half an hour after the meal for 12 weeks( each cup of Chamomile tea is produced by putting Chamomile tea bag contains 2.5 grams i
control group 3 cups of black tea daily the same period (each cup of black tea is produced by putting black tea bag contains 2.5 grams in 150 cc of boiled water at least half an hour after eating the

Sponsors

Shahid Sadooghi University of Medical Sciences and Health
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Those aged between 60-30 years with mild to moderate depression (Beck test score of 30-11). no disorders and diseases of the kidney, liver, heart, thyroid, bleeding disorders and malignancies, autoimmune diseases, and degenerative diseases of the central nervous system as the express themselves, no history of hospitalization for mental illness, not using nutritional and antioxidant supplementation and sedative and diuretics during the last 3 months, diabetes mellitus type 2 (minimum 5 and maximum 15-year history of diabetes), and usage of blood glucose lowering drugs, patients with dyslipidemia who the usual treatment continue, Pregnant and lactating absence and lack of events such as job loss, divorce or death of their relatives during the last 3 months. Exclusion criteria: having allergy to chamomile, major depression (Beck test score greater than 30), which requires special treatment, , people that during the interview noticed Thoughts of suicide, self-injury and a history of such in them and preferring not to drink tea.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Depression. Timepoint: Baseline, after 6 weeks of intervention and At the end of the intervention. Method of measurement: Beck Depression Inventory.

Secondary

MeasureTime frame
HbA1c. Timepoint: Baseline and after 12 weeks of intervention. Method of measurement: Chromatography.;LDL_C. Timepoint: Baseline and after 12 weeks of intervention. Method of measurement: Freidwald’s formula.;HDL_C. Timepoint: Baseline and after 12 weeks of intervention. Method of measurement: Colorimetry.;TG. Timepoint: Baseline and after 12 weeks of intervention. Method of measurement: Colorimetry.;TC. Timepoint: Baseline and after 12 weeks of intervention. Method of measurement: Colorimetry.;TAC. Timepoint: Baseline and after 12 weeks of intervention. Method of measurement: Reduction DPPH.;MDA. Timepoint: Baseline and after 12 weeks of intervention. Method of measurement: Thiobarbituric Acid.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactProf. Hassan Mozaffari Khosravi

Shahid Sadooghi University of Medical Sciences and Health Services in Yazd

mozaffari.kh@gmail.com+98 35 3624 0691

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026